• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.23% Nasdaq Up1.74%

    Interleukin Genetics, Inc. (ILIU)

    -Other OTC
    0.12 Down 0.00(0.08%) Oct 2, 2:45PM EDT
    ProfileGet Profile for:
    Interleukin Genetics, Inc.
    135 Beaver Street
    Waltham, MA 02452
    United States - Map
    Phone: 781-398-0700
    Fax: 781-398-0720
    Website: http://www.ilgenetics.com

    Index Membership:N/A
    Full Time Employees:N/A

    Business Summary 

    Interleukin Genetics, Inc. focuses on the development and commercialization of personalized health products that help individuals to improve and maintain their health through preventive measures in the United States. It offers PerioPredict, a genetic test to analyze genetic variations associated with inflammation and identify individuals with risk for periodontal disease. The company also provides weight management, bone health, heart health, nutritional needs, and wellness select genetic tests under the Inherent Health brand. It is also involved in the development of osteoarthritis genetic tests to detect adult joint diseases. The company markets its Inherent Health brand of genetic tests through its e-commerce Website, and under contract with Amway and various regional weight management focused organizations. It has clinical research collaborations with Stanford University, the University of North Carolina, the Mayo Clinic, Brigham & Women’s Hospital, University of California, New York University Medical Center, University of Sheffield, Yonsei University Medical Center, Tongji Medical College, Tuft’s University Medical Center, and Geisinger Clinic for the research and development of genetic tests. The company was founded in 1986 and is based in Waltham, Massachusetts.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Interleukin Genetics, Inc.

    Key Executives 
    Dr. Kenneth S. Kornman D.D.S., PH.D., 67
    Founder, Pres, Chief Scientific Officer, Sec. and Director
    Mr. Stephen J. DiPalma M.B.A, 56
    Chief Financial Officer
    Mr. Scott A. Snyder , 54
    Chief Marketing Officer
    Mr. Mark B. Carbeau , 54
    Chief Exec. Officer and Director
    Dr. Lynn Doucette-Stamm Ph.D.,
    VP of Devel. & Clinical Operations
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders